0.5401
price up icon0.95%   0.0051
after-market Dopo l'orario di chiusura: .52 -0.0201 -3.72%
loading
Precedente Chiudi:
$0.535
Aprire:
$0.5416
Volume 24 ore:
75,561
Relative Volume:
0.18
Capitalizzazione di mercato:
$22.43M
Reddito:
$9.57M
Utile/perdita netta:
$-43.11M
Rapporto P/E:
-0.3234
EPS:
-1.67
Flusso di cassa netto:
$-49.54M
1 W Prestazione:
-8.44%
1M Prestazione:
+18.47%
6M Prestazione:
-27.44%
1 anno Prestazione:
-50.68%
Intervallo 1D:
Value
$0.5228
$0.5491
Intervallo di 1 settimana:
Value
$0.4963
$0.5898
Portata 52W:
Value
$0.4112
$5.95

Spruce Biosciences Inc Stock (SPRB) Company Profile

Name
Nome
Spruce Biosciences Inc
Name
Telefono
(415) 655-4168
Name
Indirizzo
611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO
Name
Dipendente
22
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
SPRB's Discussions on Twitter

Spruce Biosciences Inc Stock (SPRB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-12-17 Iniziato Oppenheimer Outperform
2021-12-10 Iniziato The Benchmark Company Speculative Buy
2021-11-16 Downgrade SVB Leerink Outperform → Mkt Perform
2021-07-19 Iniziato H.C. Wainwright Buy
2021-04-26 Ripresa Credit Suisse Outperform
2020-11-03 Iniziato Cowen Outperform
2020-11-03 Iniziato Credit Suisse Outperform
2020-11-03 Iniziato RBC Capital Mkts Outperform
2020-11-03 Iniziato SVB Leerink Outperform
Mostra tutto

Spruce Biosciences Inc Borsa (SPRB) Ultime notizie

pulisher
Nov 01, 2024

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

Nov 01, 2024
pulisher
Oct 28, 2024

Spruce Biosciences faces Nasdaq delisting notice By Investing.com - Investing.com South Africa

Oct 28, 2024
pulisher
Oct 28, 2024

Spruce Biosciences faces Nasdaq delisting notice - Investing.com

Oct 28, 2024
pulisher
Oct 28, 2024

Spruce Biosciences to Participate in the Guggenheim Securities Healthcare Innovation Conference - StockTitan

Oct 28, 2024
pulisher
Oct 22, 2024

Global Adrenogenital Syndrome Treatment Market to Reach USD 22.08 Billion in 2033, Driven by New The - PharmiWeb.com

Oct 22, 2024
pulisher
Oct 22, 2024

Congenital Adrenal Hyperplasia Clinical Trials 2024: FDA Approvals, Companies, Medication, Treatment Market, Therapies, ROA and MOA by DelveInsight | Becton, Dickinson and Company, Cook Medical, MORE - Barchart

Oct 22, 2024
pulisher
Oct 16, 2024

Floyd Mayweather Jr buying $402M Black Spruce portfolio - Yahoo Finance

Oct 16, 2024
pulisher
Oct 15, 2024

Congenital Adrenal Hyperplasia (CAH) Therapeutic Market 2024 - openPR

Oct 15, 2024
pulisher
Oct 12, 2024

Ambev S.A. (NYSE:ABEV) Given Average Rating of “Hold” by Brokerages - Defense World

Oct 12, 2024
pulisher
Oct 10, 2024

Daily Progress: Spruce Biosciences Inc (SPRB) Drop -5.56, Closing at 0.43 - The Dwinnex

Oct 10, 2024
pulisher
Oct 10, 2024

The Significance of Moving Averages in Spruce Biosciences Inc Inc. (SPRB) Price Performance - The InvestChronicle

Oct 10, 2024
pulisher
Oct 03, 2024

A closer look at Spruce Biosciences Inc (SPRB)’s stock price trends - US Post News

Oct 03, 2024
pulisher
Oct 02, 2024

North Carolina town that produces quartz needed for tech products is devastated by Helene - Yahoo Finance

Oct 02, 2024
pulisher
Sep 30, 2024

Spruce Biosciences' SWOT analysis: tildacerfont trials key for CAH stock - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

Spruce Biosciences' SWOT analysis: tildacerfont trials key for CAH stock By Investing.com - Investing.com UK

Sep 30, 2024
pulisher
Sep 24, 2024

Recent Insider Activity Suggests Potential Gains for Spruce Biosciences Inc (SPRB) - Knox Daily

Sep 24, 2024
pulisher
Sep 20, 2024

Spruce Biosciences Inc (SPRB) expanding its growth trajectory ahead - SETE News

Sep 20, 2024
pulisher
Sep 19, 2024

Spruce Biosciences Inc [SPRB] stock for 350,951 USD was sold by Novo Holdings A/S - Knox Daily

Sep 19, 2024
pulisher
Sep 19, 2024

Spruce Biosciences Inc’s results are impressive - US Post News

Sep 19, 2024
pulisher
Sep 19, 2024

Financial Fitness Check: Examining Spruce Biosciences Inc (SPRB)’s Key Ratios - The Dwinnex

Sep 19, 2024
pulisher
Sep 11, 2024

Checking in on Spruce Biosciences Inc (SPRB) after recent insiders movement - Knox Daily

Sep 11, 2024
pulisher
Sep 10, 2024

Life Time Group Holdings Inc (LTH) gets rating Initiated from Craig Hallum - Knox Daily

Sep 10, 2024
pulisher
Sep 03, 2024

Spruce Biosciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance

Sep 03, 2024
pulisher
Sep 02, 2024

Potential Price Increase for Spruce Biosciences Inc (SPRB) After Recent Insider Activity - Knox Daily

Sep 02, 2024
pulisher
Sep 01, 2024

SPRBSpruce Biosciences, Inc. Latest Stock News & Market Updates - StockTitan

Sep 01, 2024
pulisher
Sep 01, 2024

An Inquiry Has Been Launched Into Whether Spruce Biosciences Inc. Violated Securities Regulations And Stockholders Are Encouraged To Assist - StockTitan

Sep 01, 2024
pulisher
Aug 21, 2024

Spruce Biosciences Inc (SPRB) Becoming More Attractive for Investors - Knox Daily

Aug 21, 2024
pulisher
Aug 19, 2024

SPRB (Spruce Biosciences) Profitability Rank : 1 (As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 18, 2024

SPRB (Spruce Biosciences) Dividends per Share : $0.00 (TTM As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 17, 2024

Spruce Power Holding Second Quarter 2024 Earnings: US$0.46 loss per share (vs US$0.17 profit in 2Q 2023) - Yahoo Finance

Aug 17, 2024
pulisher
Aug 14, 2024

Spruce Biosciences (NASDAQ:SPRB) Issues Quarterly Earnings Results, Beats Expectations By $0.10 EPS - Defense World

Aug 14, 2024
pulisher
Aug 14, 2024

What technical indicators reveal about SPRB stock - US Post News

Aug 14, 2024
pulisher
Aug 14, 2024

Spruce Biosciences’ (SPRB) Sector Perform Rating Reaffirmed at Royal Bank of Canada - Defense World

Aug 14, 2024
pulisher
Aug 13, 2024

Spruce Biosciences Inc [SPRB] Insider Activity: An Update for Investors - Knox Daily

Aug 13, 2024
pulisher
Aug 13, 2024

Ratios Reveal: Breaking Down Spruce Biosciences Inc (SPRB)’s Financial Health - The Dwinnex

Aug 13, 2024
pulisher
Aug 13, 2024

SPRB stock touches 52-week low at $0.42 amid market challenges - Investing.com Australia

Aug 13, 2024
pulisher
Aug 12, 2024

SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024 - InvestorPlace

Aug 12, 2024
pulisher
Aug 12, 2024

Spruce Biosciences, Inc. (SPRB) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Aug 12, 2024
pulisher
Aug 12, 2024

Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - Manchestertimes

Aug 12, 2024
pulisher
Aug 10, 2024

Is Spruce Biosciences Inc (NASDAQ: SPRB) A Good Investment Now? - Stocks Register

Aug 10, 2024
pulisher
Aug 08, 2024

Taking a look at what insiders are doing to gauge the Spruce Biosciences Inc (SPRB)’s direction - Knox Daily

Aug 08, 2024
pulisher
Aug 08, 2024

Have you been able to find a good deal on Spruce Biosciences Inc’s shares? - US Post News

Aug 08, 2024
pulisher
Aug 08, 2024

Market Recap: Spruce Biosciences Inc (SPRB)’s Negative Momentum, Closing at 0.45 - The Dwinnex

Aug 08, 2024
pulisher
Aug 05, 2024

Nothing is Better Than Spruce Biosciences Inc (SPRB) stock at the moment - SETE News

Aug 05, 2024
pulisher
Aug 05, 2024

Analysts review Spruce Biosciences Inc’s rating - Knox Daily

Aug 05, 2024
pulisher
Aug 02, 2024

Ratio Revelations: Spruce Biosciences Inc (SPRB)’s Financial Metrics in the Spotlight - The Dwinnex

Aug 02, 2024
pulisher
Aug 02, 2024

SPRB stock touches 52-week low at $0.5 amid market challenges - Investing.com

Aug 02, 2024
pulisher
Jul 31, 2024

Spruce Biosciences Inc [SPRB] Investment Appeal on the Rise - Knox Daily

Jul 31, 2024
pulisher
Jul 30, 2024

Investors With Losses Are Urged To Initiate Dialogue As Spruce B - WICZ

Jul 30, 2024
pulisher
Jul 29, 2024

Investors With Losses Are Urged To Initiate Dialogue As Spruce Biosciences Inc Is Being Investigated By The Schall Law Firm - AccessWire

Jul 29, 2024
pulisher
Jul 29, 2024

The Schall Law Firm Is Carrying Out An Investigation Into Spruce - WICZ

Jul 29, 2024

Spruce Biosciences Inc Azioni (SPRB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Spruce Biosciences Inc Azioni (SPRB) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Novo Holdings A/S
10% Owner
Mar 18 '24
Sale
0.77
842,020
647,008
3,968,000
Novo Holdings A/S
10% Owner
Mar 19 '24
Sale
0.76
593,000
447,715
3,375,000
Novo Holdings A/S
10% Owner
Mar 20 '24
Sale
0.73
359,979
264,081
3,015,021
Novo Holdings A/S
10% Owner
Mar 14 '24
Sale
0.89
1,912,316
1,698,902
4,810,020
Charlton Ralph William III
Chief Medical Officer
Dec 15 '23
Option Exercise
0.00
31,750
0
56,992
Gharib Samir M.
President & CFO
Dec 15 '23
Option Exercise
0.00
112,250
0
204,403
Szwarcberg Javier B.
Chief Executive Officer
Dec 15 '23
Option Exercise
0.00
111,000
0
145,705
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):